Company Filing History:
Years Active: 2022
Title: Sunil Shantwan Borude: Innovator in Prolonged-Release Pharmaceutical Compositions
Introduction
Sunil Shantwan Borude is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral solid compositions for prolonged-release medications. His innovative work aims to improve treatment options for patients suffering from vestibular diseases.
Latest Patents
Sunil holds a patent for a "Non-pulsatile prolonged-release betahistine oral solid composition." This composition includes an amount of betahistine, or a pharmaceutically acceptable salt thereof, equivalent to 48 mg of betahistine dihydrochloride. The formulation is designed to provide a controlled release of the active ingredient over a 24-hour period, with specific dissolution profiles at various time intervals. This innovation is particularly relevant for the treatment of Menière's disease, a condition affecting the inner ear.
Career Highlights
Sunil is currently associated with Intas Pharmaceuticals Limited, where he continues to work on advancing pharmaceutical technologies. His expertise in formulating prolonged-release compositions has positioned him as a valuable asset in the industry.
Collaborations
Sunil collaborates with talented professionals in his field, including Himanshukumar Dasharathlal Patel and Vinod Purushottam Dube. Their combined efforts contribute to the development of innovative pharmaceutical solutions.
Conclusion
Sunil Shantwan Borude's work in the pharmaceutical industry exemplifies the impact of innovation on healthcare. His patented compositions not only enhance the efficacy of treatments but also improve the quality of life for patients with vestibular conditions.